Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 13/20 | 0.71 |
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.71 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | CDC25B | P30305 | 1/20 | 0.46 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22735168 | 1.00 | PPARG (0.71) | PPARGNFE2L2LMNAPTGES2ALDH1A1 | |
| SCHEMBL27591358 | 0.84 | PPARG (1.00) | PPARGNFE2L2LMNA | |
| SCHEMBL14492053 | 0.84 | PPARG (1.00) | PPARGNFE2L2LMNA | |
| SCHEMBL28192166 | 0.82 | PPARG (0.96) | PPARGNFE2L2LMNA | |
| SCHEMBL28240283 | 0.82 | PPARG (0.96) | PPARGNFE2L2LMNA | |
| SCHEMBL2978879 | 0.80 | PPARG (0.77) | PPARGNFE2L2LMNA | |
| SCHEMBL2978881 | 0.80 | PPARG (0.77) | PPARGNFE2L2LMNA | |
| SCHEMBL22735360 | 0.78 | PPARG (0.91) | PPARGNFE2L2LMNAALDH1A1 | |
| SCHEMBL22735359 | 0.78 | PPARG (0.91) | PPARGNFE2L2LMNAALDH1A1 | |
| SCHEMBL14492063 | 0.78 | PPARG (0.86) | PPARGNFE2L2LMNAPTPN1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11901508-B2 | Silicon-based energy storage devices with functionalized linear sulfonate ester derivative compound containing electrolyte additives | ENEVATE CORPORATION (US) | 2024-02-13 | — | — | US | claimed |
| US-20230006252-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONALIZED LINEAR SULFONATE ESTER DERIVATIVE COMPOUND CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2023-01-05 | — | — | US | claimed |
| US-20200388879-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONALIZED LINEAR SULFONATE ESTER DERIVATIVE COMPOUND CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-12-10 | — | — | US | claimed |
| US-11901508-B2 | Silicon-based energy storage devices with functionalized linear sulfonate ester derivative compound containing electrolyte additives | ENEVATE CORPORATION (US) | 2024-02-13 | — | — | US | disclosed |
| US-20230006252-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONALIZED LINEAR SULFONATE ESTER DERIVATIVE COMPOUND CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2023-01-05 | — | — | US | disclosed |
| US-11431029-B2 | Silicon-based energy storage devices with functionalized linear sulfonate ester derivative compound containing electrolyte additives | ENEVATE CORPORATION (US) | 2022-08-30 | — | — | US | disclosed |
| US-20200388879-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONALIZED LINEAR SULFONATE ESTER DERIVATIVE COMPOUND CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200388879-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONALIZED LINEAR SULFONATE ESTER DERIVATIVE COMPOUND CONTAINING ELECTROLYTE ADDITIVES | SELENOI, SELE, SORD | PPARG 1293/4885NFE2L2 1871/4885LMNA 2950/4885 |
| US-11901508-B2 | Silicon-based energy storage devices with functionalized linear sulfonate ester derivative compound containing electrolyte additives | SELENOI, SELE, SORD | PPARG 1293/4885NFE2L2 1871/4885LMNA 2950/4885 |
| US-11431029-B2 | Silicon-based energy storage devices with functionalized linear sulfonate ester derivative compound containing electrolyte additives | SELENOI, SELE, SORD | PPARG 1293/4885NFE2L2 1871/4885LMNA 2950/4885 |
| US-20230006252-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONALIZED LINEAR SULFONATE ESTER DERIVATIVE COMPOUND CONTAINING ELECTROLYTE ADDITIVES | SELENOI, SELE, SORD | PPARG 1293/4885NFE2L2 1871/4885LMNA 2950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.